Jill Durocher
Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone
- Published
- June 30th, 2009
- Type
- Publication
- Topic
- Medical Abortion
- Authors
- Winikoff, Beverly, Dabash, Rasha, Akın, A., Dilbaz, B, Aktun, H., Dursun, P., Kıran, S., Aksan, G., Dogan, B.
Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75; doi:10.1080/13625180902916020
This article reports on results of a clinical trial evaluating two routes of misoprostol administration following mifepristone for early medical abortion. For gestations through 56 days since last menstrual period 400mcg of oral misoprostol performed better than a 400mcg sublingual dose when following 200mg mifepristone although not significantly so.